Percutaneous coronary interventions affect concentrations of interleukin 6 and its soluble receptors in coronary sinus blood in patients with stable angina

Angiology

Volumn 60, Issue 3, 2009, Pages 322-328

  Kamiłski, Karol A ^a   Kozieradzka, Anna ^a   Bonda, Tomasz ^a   Banach, MacIej ^b   Kozuch, Marcin ^b   Wojtkowska, Izabela ^a   Dobrzycki, Sławomir ^c   Kralisz, Paweł ^a   Nowak, Konrad ^b   Prokopczuk, Przemysław ^b   Mikhailidis, Dimitri P ^d   Musial, Wlodzimierz J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c INSTITUTE OF CARDIOLOGY   (Poland)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Coronary stenting; Inflammation; Interleukin 6; Ischemic heart disease

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOPROTEIN GP 130; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; IL6ST PROTEIN, HUMAN;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; CORONARY STENT; CYTOKINE PRODUCTION; ELECTIVE SURGERY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; ANGINA PECTORIS; BLOOD; HEART MUSCLE ISCHEMIA; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; REFERENCE VALUE; SIGNAL TRANSDUCTION; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY SINUS; CYTOKINE RECEPTOR GP130; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; REFERENCE VALUES; SIGNAL TRANSDUCTION; STENTS;

EID: 67849114301     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319708330008     Document Type: Article

References (25)

1. Li JJ, Qin XW, Yang XC, et al. Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions. Clin Chim Acta. 2008 ; 396: 38-42.
2. Ferrero V., Ribichini F., Pesarini G., Brunelleschi S., Vassanelli C. Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential. Drugs. 2007 ; 67: 1243-1255.
3. Kanjilal S., Shanker J., Rao VS, et al. Association of metabolic syndrome with atherothrombotic blood phenotypes in Asian Indian families with premature coronary artery disease. Arch Med Sci. 2008 ; 4: 145-151.
4. Kopf M., Baumann H., Freer G., et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 1994 ; 368: 339-342.
5. Schieffer B., Selle T., Hilfiker A., et al. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation. 2004 ; 110: 3493-3500.
6. Dawn B., Xuan YT, Guo Y., et al. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res. 2004 ; 64: 61-71.
7. Rose-John S., Scheller J., Elson G., et al. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol. 2006 ; 80: 227-236.
8. Rose-John S., Waetzig GH, Scheller J., Grötzinger J., Seegert D. The IL-6/sIL-6R complex as a novel target for therapeutic approaches. Expert Opin Ther Targets. 2007 ; 11: 613-624.
9. Hojo Y., Ikeda U., Katsuki T., et al. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart. 2000 ; 84: 83-87.
10. Bossowska A., Kiersnowska-Rogowska B., Bossowski A., et al. Cytokines in patients with ischaemic heart disease or myocardial infarction. Kardiol Pol. 2003 ; 59: 105-114.
11. Kinlay S., Schwartz GG, Olsson AG, et al. Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study. Arterioscler Thromb Vasc Biol. 2008 ; 28: 142-147.
12. Kowalski J., Barylski M., Banach M., Grycewicz J., Irzmałski R., Pawlicki L. Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention. J Cardiovasc Pharmacol. 2006 ; 48: 143-147.
13. Athyros VG, Kakafika AI, Karagiannis A., Mikhailidis DP Do we need to consider inflammatory markers when we treat atherosclerotic disease ? Atherosclerosis. 2008 ; 200: 1-12.
14. Kefer JM, Galanti LM, Desmet S., et al. Time course of release of inflammatory markers after coronary stenting: comparison between bare metal stent and sirolimus-eluting stent. Coron Artery Dis. 2005 ; 16: 505-509.
15. Sardella G., Mariani P., D'Alessandro M., et al. Early elevation of interleukin-1beta and interleukin-6 levels after bare or drug-eluting stent implantation in patients with stable angina. Thromb Res. 2006 ; 117: 659-664.
16. Ichiki T., Jougasaki M., Setoguchi M., et al. Plasma levels of soluble glycoprotein 130 in acute myocardial infarction. J Cardiol. 2007 ; 50: 101-109.
17. Hirota H., Izumi M., Hamaguchi T., et al. Circulating interleukin-6 family cytokines and their receptors in patients with congestive heart failure. Heart Vessels. 2004 ; 19: 237-241.
18. Deten A., Volz HC, Briest W., Zimmer HG Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res. 2002 ; 55: 329-340.
19. Memoli B., Grandaliano G., Soccio M., et al. In vivo modulation of soluble ''antagonistic'' IL-6 receptor synthesis and release in ESRD. J Am Soc Nephrol. 2005 ; 16: 1099-1107.
20. Schipke JD, Halkos ME, Kerendi F., Gams E., Vinten-Johansen J. Postconditioning: a brief review. Arch Med Sci. 2006 ; 2: 137-145.
21. Boengler K., Buechert A., Heinen Y., et al. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res. 2008 ; 102: 131-135.
22. Oka H., Ikeda S., Koga S., Miyahara Y., Kohno S. Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases. Heart Vessels. 2008 ; 23: 249-256.
23. Tsitouras PD, Gucciardo F., Salbe AD, Heward C., Harman SM High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res. 2008 ; 40: 199-205.
24. Kowalski J., Banach M., Barylski M., Irzmanski R., Pawlicki L. Carvedilol modifies antioxidant status of patients with stable angina. Cell Mol Biol Lett. 2008 ; 13: 230-239.
25. Merino A., Gayá A., Segura I., Calvo J., Imzcoz C., Berenguel A., Alegra E. Platelet aggregation inhibition blocks C-reactive protein and interleukin-6 (IL-6) elevation after the coronary angioplasty: effect of the -174 G/C IL-6 gene polymorphism. Am J Cardiol. 2004 ; 94: 1300-1303.